Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.6B | 1.7B | 1.8B | 1.7B |
Cost of revenue | 1.2B | 1.4B | 1.4B | 1.3B |
Gross profit | 354.0M | 369.8M | 360.3M | 351.5M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 244.1M | 264.6M | 246.2M | 223.3M |
Other operating expenses | — | — | — | — |
Operating income | 109.9M | 105.1M | 114.1M | 128.3M |
Non operating interest income | ||||
Income | 2.1M | 2.2M | 4.2M | 3.8M |
Expense | 12.2M | 12.5M | 13.0M | 13.0M |
Other income expense | 948K | 185.9M | 2.8M | -15.9M |
Pretax income | 100.8M | 280.8M | 108.1M | 103.1M |
Tax provision | 19.0M | 64.3M | 22.5M | 22.4M |
Net income | 81.8M | 216.5M | 85.6M | 80.7M |
Basic EPS | — | 0.5 | 0.7 | 0.7 |
Diluted EPS | — | 0.5 | 0.7 | 0.6 |
Basic average shares | — | 106.5M | 106.3M | 106.3M |
Diluted average shares | — | 111.8M | 111.1M | 110.5M |
EBITDA | 140.4M | 319.0M | 145.7M | 140.6M |
Net income from continuing op. | 81.8M | 216.5M | 85.6M | 80.7M |
Minority interests | -15.6M | -15.2M | -13.6M | -11.5M |
Preferred stock dividends | — | — | — | — |